TSP Capital Management Group’s Pfizer PFE Stock Holding History

TSP Capital Management Group’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$662K	Buy	+27,500	New	+$719K	0.16%	41
2026 Q1	–	Hold	0	–	–	–	40
2025 Q4	–	Sell	-44,100	Closed	-$1.11M	–	40
2025 Q3	$1.12M	Buy	+44,100	New	+$1.09M	0.3%	37
2025 Q2	–	Sell	-44,100	Closed	-$1.03M	–	35
2025 Q1	$1.12M	Sell	44,100 -600	-1%	-$15.7K	0.37%	37
2024 Q4	$1.19M	Hold	44,700	–	–	0.4%	37
2024 Q3	$1.29M	Hold	44,700	–	–	0.4%	37
2024 Q2	$1.25M	Hold	44,700	–	–	0.39%	37
2024 Q1	$1.24M	Hold	44,700	–	–	0.4%	38
2023 Q4	$1.29M	Sell	44,700 -40	-0.1%	-$1.21K	0.45%	36
2023 Q3	$1.48M	Sell	44,740 -3,000	-6%	-$106K	0.57%	32
2023 Q2	$1.75M	Sell	47,740 -1,640	-3%	-$63.8K	0.63%	33
2023 Q1	$2.01M	Sell	49,380 -1,700	-3%	-$73.4K	0.73%	33
2022 Q4	$2.62M	Buy	+51,080	New	+$2.45M	0.98%	28
2022 Q3	–	Hold	0	–	–	–	29
2022 Q2	–	Hold	0	–	–	–	28
2022 Q1	–	Hold	0	–	–	–	26
2021 Q4	–	Hold	0	–	–	–	26
2021 Q3	–	Hold	0	–	–	–	30
2021 Q2	–	Sell	-51,080	Closed	-$1.99M	–	33
2021 Q1	$1.85M	Sell	51,080 -960	-2%	-$34.1K	0.65%	33
2020 Q4	$1.92M	Buy	+52,040	New	+$1.91M	0.68%	28
2020 Q3	–	Hold	0	–	–	–	28
2020 Q2	–	Hold	0	–	–	–	31
2020 Q1	–	Hold	0	–	–	–	28
2019 Q4	–	Hold	0	–	–	–	28
2019 Q3	–	Hold	0	–	–	–	26
2019 Q2	–	Hold	0	–	–	–	25
2019 Q1	–	Sell	-57,313	Closed	-$2.3M	–	26
2018 Q4	$2.37M	Buy	+57,313	New	+$2.38M	1.33%	28
2018 Q3	–	Sell	-59,843	Closed	-$2.3M	–	27
2018 Q2	$2.06M	Sell	59,843 -1,054	-2%	-$36K	1.06%	29
2018 Q1	$2.05M	Sell	60,897 -2,055	-3%	-$70.6K	0.98%	31
2017 Q4	$2.16M	Sell	62,952 -527	-0.8%	-$18K	0.98%	29
2017 Q3	$2.15M	Buy	+63,479	New	+$2.04M	1.03%	30
2017 Q2	–	Hold	0	–	–	–	31
2017 Q1	–	Hold	0	–	–	–	31
2016 Q4	–	Hold	0	–	–	–	33
2016 Q3	–	Sell	-65,324	Closed	-$2.18M	–	29
2016 Q2	$2.18M	Sell	65,324 -685	-1%	-$21.9K	1.13%	28
2016 Q1	$1.86M	Sell	66,009 -2,797	-4%	-$79.9K	1.02%	30
2015 Q4	$2.11M	Sell	68,806 -685	-1%	-$21.5K	1.13%	28
2015 Q3	$2.07M	Sell	69,491 -6,851	-9%	-$220K	1.16%	26
2015 Q2	$2.43M	Buy	+76,342	New	+$2.49M	1.13%	29
2015 Q1	–	Hold	0	–	–	–	27
2014 Q4	–	Hold	0	–	–	–	29
2014 Q3	–	Sell	-86,461	Closed	-$2.43M	–	30
2014 Q2	$2.44M	Buy	+86,461	New	+$2.46M	1.06%	29
2014 Q1	–	Hold	0	–	–	–	26
2013 Q4	–	Hold	0	–	–	–	29
2013 Q3	–	Hold	0	–	–	–	30
2013 Q2	–	Hold	0	–	–	–	28

Other funds holding PFE

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

SLAM

Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

CWP

Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

TSP Capital Management Group's PFE Position: Q2 2026 in Review

TSP Capital Management Group opened a new position in Pfizer (PFE) in Q2 2026: 27,500 shares worth $662K. The stake represents 0.16% of the portfolio and ranks #41 among its holdings. This is a return to the name: TSP Capital Management Group previously reported a position in PFE as recently as Q3 2025.

TSP Capital Management Group first reported a position in PFE in Q2 2014 and has held it in 25 quarters since. The position peaked at $2.62M in Q4 2022. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

TSP Capital Management Group held 27,500 shares of Pfizer worth $662K as of Q2 2026.
Pfizer was a new TSP Capital Management Group position in Q2 2026.
Pfizer made up 0.16% of TSP Capital Management Group's portfolio in Q2 2026, its #41 holding.
TSP Capital Management Group first reported a position in Pfizer in Q2 2014 and has held it in 25 quarters since.
TSP Capital Management Group's Pfizer position peaked at $2.62M in Q4 2022.
1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on TSP Capital Management Group's 13F filing for Q2 2026, filed 31 Jul 2026.